HCPLive
American Neurological Association 2013 Annual Meeting

American Neurological Association 2013 Annual Meeting | ANA 2013

The American Neurological Association 2013 Annual Meeting "will offer scientific symposia on remyelination, multiple sclerosis, stroke, epilepsy, and neuro-repair, plus Special Interest Group Symposia on 17 different subspecialties." It will also feature "a ground-breaking Public Policy Symposium that will bring together experts to discuss the implications of the Affordable Health Care Act on neurology and neuroscience."

Conference Coverages

Rivastigmine Patch Shows Global Benefit in Severe Alzheimer’s Disease
Rivastigmine Patch Shows Global Benefit in Severe Alzheimer’s Disease
Patients with advanced Alzheimer’s disease treated with 13.3 mg rivastigmine patch showed greater improvements in cognitive, functional, and behavioral performance from baseline compared to patients who received 4.6 mg patches.
High Rates of Neuroimaging in Outpatient Headache Visits
Despite current guideline recommendations against the use of routine neuroimaging for uncomplicated headaches, physicians still tend to order imaging tests for many patients who present with headache and migraine, driving up annual healthcare spending.
Memantine with Donepezil Superior to Single Treatment in Moderate to Severe Alzheimer’s Disease
Study results show that patients who received combination treatment demonstrated improvements in cognition, function, and behavioral outcomes compared to treatment with either medication alone or placebo.
New Carbidopa-Levodopa Formulation Improves Motor Control in Patients with Parkinson’s Disease
Patients with advanced Parkinson’s disease treated with an investigational extended-release carbidopa-levodopa formulation experienced greater reductions in “off” time and greater improvement in dyskinesia-free “on” time compared with similar patients treated with carbidopa-levodopa plus entacapone.
Coenzyme Q10 Well-tolerated in Patients with Huntington Disease Participating in a Multi-center Phase II Trial
Results from the first multi-center interventional trial in premanifest HD research show that the antioxidant Coenzyme Q10 is associated with only mild or moderate side effects, even at higher doses.
Anxiety and Depression Are Often Comorbid with Psychosis in Parkinson’s Disease
Study results indicate a significant correlation between depression and hallucination in patients with Parkinson’s disease, while anxiety is a significant predictor for both the number and severity of hallucinations.
Expanding Access to Acute Stroke Care through Telemedicine
Study shows that the use of telemedicine by primary stroke centers and other hospitals increases access to specialized stroke care for patients living in rural and medically underserved areas.

Most Popular

$vacMongoViewPlus$ $vAR$